Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

463 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lifestyle intervention for pre-diabetic neuropathy.
Smith AG, Russell J, Feldman EL, Goldstein J, Peltier A, Smith S, Hamwi J, Pollari D, Bixby B, Howard J, Singleton JR. Smith AG, et al. Among authors: howard j. Diabetes Care. 2006 Jun;29(6):1294-9. doi: 10.2337/dc06-0224. Diabetes Care. 2006. PMID: 16732011
Biosensor and machine learning-aided engineering of an amaryllidaceae enzyme.
d'Oelsnitz S, Diaz DJ, Kim W, Acosta DJ, Dangerfield TL, Schechter MW, Minus MB, Howard JR, Do H, Loy JM, Alper HS, Zhang YJ, Ellington AD. d'Oelsnitz S, et al. Among authors: howard jr. Nat Commun. 2024 Mar 7;15(1):2084. doi: 10.1038/s41467-024-46356-y. Nat Commun. 2024. PMID: 38453941 Free PMC article.
Circular Dichroism Sensing: Strategies and Applications.
Formen JSSK, Howard JR, Anslyn EV, Wolf C. Formen JSSK, et al. Among authors: howard jr. Angew Chem Int Ed Engl. 2024 Feb 29:e202400767. doi: 10.1002/anie.202400767. Online ahead of print. Angew Chem Int Ed Engl. 2024. PMID: 38421186 Review.
Improvement of fatigue in generalised myasthenia gravis with zilucoplan.
Weiss MD, Freimer M, Leite MI, Maniaol A, Utsugisawa K, Bloemers J, Boroojerdi B, Howard E, Savic N, Howard JF Jr. Weiss MD, et al. Among authors: howard jf jr. J Neurol. 2024 Feb 24. doi: 10.1007/s00415-024-12209-3. Online ahead of print. J Neurol. 2024. PMID: 38400914
Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis.
Howard JF Jr, Bril V, Vu T, Karam C, Peric S, De Bleecker JL, Murai H, Meisel A, Beydoun SR, Pasnoor M, Guglietta A, Van Hoorick B, Steeland S, T'joen C, Utsugisawa K, Verschuuren J, Mantegazza R; ADAPT+ Study Group. Howard JF Jr, et al. Front Neurol. 2024 Jan 17;14:1284444. doi: 10.3389/fneur.2023.1284444. eCollection 2023. Front Neurol. 2024. PMID: 38318236 Free PMC article.
463 results